Xodus Medical Inc v. Prime Medical LLC

CourtDistrict Court, E.D. Tennessee
DecidedJanuary 27, 2022
Docket3:18-cv-00413
StatusUnknown

This text of Xodus Medical Inc v. Prime Medical LLC (Xodus Medical Inc v. Prime Medical LLC) is published on Counsel Stack Legal Research, covering District Court, E.D. Tennessee primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Xodus Medical Inc v. Prime Medical LLC, (E.D. Tenn. 2022).

Opinion

IN THE UNITED STATES DISTRICT COURT FOR THE EASTERN DISTRICT OF TENNESSEE NORTHERN DIVISION

XODUS MEDICAL, INC., ) ALESSIO PIGAZZI, and GLENN KEILAR, ) ) Plaintiffs, ) ) v. ) No. 3:18-cv-413-JPM ) PRIME MEDICAL, LLC., and ) SYMMETRY SURGICAL INC. ) ) Defendants. ) ______________________________________________________________________________ XODUS MEDICAL, INC., ) ALESSIO PIGAZZI, and GLENN KEILAR, ) ) Plaintiffs, ) ) v. ) No. 3:18-cv-414-JPM ) PRIME MEDICAL, LLC., and ) SYMMETRY SURGICAL INC. ) ) Defendants. ) ______________________________________________________________________________ XODUS MEDICAL, INC., ) ALESSIO PIGAZZI, and GLENN KEILAR, ) ) Plaintiffs, ) ) v. ) No. 3:18-cv-415-JPM ) G&T INDUSTRIES, INC. ) ) Defendant. )

ORDER DENYING DEFENDANTS’ MOTION TO PRECLUDE PLAINTIFFS’ USE OF THEIR SALES-FIGURES SPREADSHEET Before the Court is Defendants Prime Medical, LLC (“Prime”), Symmetry Surgical Inc., and G&T Industries, Inc.’s Motion to Preclude Plaintiffs’ Use of Their Sales-Figures Spreadsheet, filed under seal on November 30, 2021. (ECF No. 320.) Plaintiffs Xodus Medical, Inc. (“Xodus”), Alessio Pigazzi, and Glenn Keilar filed a Response in Opposition on December 17, 2021. (ECF

No. 345.) Defendants filed a Reply on January 3, 2022. (ECF No. 372.) For the reasons discussed below, Defendants’ Motion is DENIED. I. BACKGROUND This is a patent infringement case for technology “related to patient slippage within the [] context of the Trendelenburg position for surgery—when using a viscoelastic foam.” (Claim Construction Order, ECF No. 138 at PageID 2894.) The asserted patents are U.S. Patent No. 8,511,314 (the “’314 Patent”), U.S. Patent No. 8,464,720 (the “’720 Patent”), and U.S. Patent No. 9,161,876 (the “’876 Patent”). (Id.) Plaintiffs are seeking lost profits, and part of their evidence for those lost profits is a spreadsheet Bates-stamped XODUS004171 (the “Sales Spreadsheet”), which contains data for each individual sale of Xodus’s Pink Pad products. (ECF No. 320 at

PageID 9416; ECF No. 345 at PageID 9774.) Plaintiffs’ evidentiary support for their lost-profits claim, particularly the Sales Spreadsheet, has been the subject of a number of discovery disputes between the Parties. (See ECF No. 320 at PageID 9415–21; ECF No. 345 at PageID 9774–77.) As part of this ongoing dispute, Magistrate Judge Guyton ordered Plaintiffs to produce “underlying documentation supporting the summary spreadsheet.” (ECF No. 176 at PageID 3079.) The Sales Spreadsheet was also discussed at hearings before the Court on August 23, August 27, and October 25, 2021. (ECF Nos. 214, 215, 269.) Defendants seek to exclude the spreadsheet as a sanction for Plaintiffs’ alleged failure to comply with Magistrate Judge Guyton’s Order, and alternatively, because it is a summary under Federal Rule of Evidence 1006 for which the underlying documentation was not provided. (ECF No. 320 at PageID 9414.) II. LEGAL STANDARD A. Federal Rule of Civil Procedure 37(b)

In the event a party fails to obey a discovery order, the Court may issue the following sanctions: (i) directing that the matters embraced in the order or other designated facts be taken as established for purposes of the action, as the prevailing party claims; (ii) prohibiting the disobedient party from supporting or opposing designated claims or defenses, or from introducing designated matters in evidence; (iii) striking pleadings in whole or in part; (iv) staying further proceedings until the order is obeyed; (v) dismissing the action or proceeding in whole or in part; (vi) rendering a default judgment against the disobedient party; or (vii) treating as contempt of court the failure to obey any order except an order to submit to a physical or mental examination. Fed. R. Civ. P. 37(b)(2)(A). The Sixth Circuit considers four factors to determine whether to impose sanctions under Rule 37: The first factor is whether the party’s failure to cooperate in discovery is due to willfulness, bad faith, or fault; the second factor is whether the adversary was prejudiced by the party’s failure to cooperate in discovery; the third factor is whether the party was warned that failure to cooperate could lead to the sanction; and the fourth factor in regard to a dismissal is whether less drastic sanctions were first imposed or considered. Freeland v. Amigo, 103 F.3d 1271, 1277 (6th Cir. 1997) (citations omitted). B. Federal Rule of Evidence 1006 A party “may use a summary, chart, or calculation to prove the content of voluminous writings, recordings, or photographs that cannot be conveniently examined in court,” but said party “must make the originals or duplicates available for examination or copying, or both, by other parties at a reasonable time and place.” Fed. R. Evid. 1006. Printouts of electronically stored information are not considered summaries that fall under Rule 1006. United States v. Nixon, 694 F.3d 623, 634–35 (6th Cir. 2012) (“[T]he simple act of printing out the electronically stored records does not change their status for admissibility.”).

III. ANALYSIS Defendants assert that Plaintiffs should be precluded from using the Sales Spreadsheet as a sanction for failing to comply with Magistrate Judge Guyton’s discovery order, or in the alternative, because it is a summary under Federal Rule of Evidence 1006, and Plaintiffs failed to make the underlying records available to Defendants for examination or copying.1 (ECF No. 320 at PageID 9414.)

A. Plaintiffs have complied with Magistrate Judge Guyton’s Order. Defendants contend that Plaintiffs have not complied with the discovery order because: Although Plaintiffs have produced some supporting documents for the cost and sales figures, the missing data and discrepancies identified by Justin Blok confirm that Plaintiffs have not produced documents or information sufficient for Defendants “to verify (i) that XODUS004171 is an accurate reflection of what is in Xodus’[s] accounting system, or, even more importantly, (ii) whether XODUS004171 is an accurate report or summary of what Xodus actually made on sales of the Pink Pad.” Blok Decl. ¶ 18. The documents produced most recently, the sample manual tracing entries, raise as many questions as they answer. For example, those documents show two different prices—an “Original Unit Price” and a “Contract Unit Price”—associated with the same transaction, and it is not clear from any of the documents produced “which of the prices listed on the tracing entries, if either of them, was paid to Xodus, as opposed to being paid to a distributor.” Blok Decl. ¶ 12.

1 On reply, Defendants also raise a new argument that the Sales Spreadsheet “has hearsay within hearsay” because it “includes information provided to Xodus from third parties, namely Xodus’s distributors.” (ECF No. 372 at PageID 10313.) Plaintiffs have not had the opportunity to respond to this contention. The Rule 803(6) Exception to the Rule Against Hearsay would appear to be applicable if the distributors were acting “pursuant to a business duty.” This issue can be addressed upon completion of briefing. (ECF No.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

United States v. Ronda Nixon
694 F.3d 623 (Sixth Circuit, 2012)

Cite This Page — Counsel Stack

Bluebook (online)
Xodus Medical Inc v. Prime Medical LLC, Counsel Stack Legal Research, https://law.counselstack.com/opinion/xodus-medical-inc-v-prime-medical-llc-tned-2022.